IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on August 7, 2026

Aug. 7, 2026

IPcook Launches Monthly Subscription Plans for Residential Proxies

Indeterminate EIN Presswire

Aug. 7, 2026

Business Reporter: Workforce readiness is no longer a security issue

Indeterminate EIN Presswire

Aug. 7, 2026

EROS Universe Launches India’s Biggest AI Creator Audition Across Mumbai, Hyderabad, Bengaluru & Chennai

Indeterminate EIN Presswire

Aug. 7, 2026

AI/R lança plataforma unificada para governança de IA corporativa

Indeterminate GlobeNewswire

Aug. 7, 2026

CAYIN Technology Launches AI AudienceSense for Real-Time Facial Recognition

Indeterminate EIN Presswire

Aug. 7, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Motorsport Games to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 7, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 7, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Aug. 7, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 7, 2026

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire

Aug. 7, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Indeterminate GlobeNewswire

Aug. 7, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Aeries Technology to Report Financial Results for the Quarter Ended June 30, 2026 on August 10, 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

Cleveroad Ranks Third Among the Top 10 U.S. Financial Services Web Developers by Clutch for 2026

Indeterminate EIN Presswire

Aug. 7, 2026

QCI AGI56.1 Now Deployed to Customers Following Successful Rollout

Indeterminate GlobeNewswire

Aug. 7, 2026

GOALisB Hosts ISB Admissions Director for Live Session Busting the Biggest Myths About ISB PGP Admissions

Indeterminate EIN Presswire